 WAYNE, Pa., Dec. 15, 2022 GLOBE NEWSWIRE Teleflex Incorporated NYSE: TFX, a leading global provider of medical technologies, today announced that 400,000 patients have now been treated with the UroLift System,1 a safe, effective and minimally invasive treatment option for benign prostatic hyperplasia BPH, or enlarged prostate.2 The UroLift System is the number one minimally ... The post Teleflex Celebrates 400,000 Patients Treated With the Minimally Invasive UroLift System appeared fi... 